New therapies have raised Medicare treatment costs for metastatic prostate cancer
byWolters Kluwer HealthTrends in the receipt of antineoplastic drugs in the first 2 years following patients’ index date. The height of the bar represents the proportion of patients receiving do
Updated on: January 15,2024
11

New therapies have raised Medicare treatment costs for metastatic prostate cancer
byWolters Kluwer HealthTrends in the receipt of antineoplastic drugs in the first 2 years following patients’ index date. The height of the bar represents the proportion of patients receiving do
Updated on:January 15,2024
11
